4.5 Article

A Synchronized Prescription Refill Program Improved Medication Adherence

期刊

HEALTH AFFAIRS
卷 35, 期 8, 页码 1504-1512

出版社

PROJECT HOPE
DOI: 10.1377/hlthaff.2015.1456

关键词

-

资金

  1. Humana Inc
  2. Amgen Inc.
  3. Merck Co. Inc.
  4. Pharmaceutical Research and Manufacturers of America (PhRMA)
  5. National Pharmaceutical Council
  6. Aetna Foundation
  7. Aramark
  8. Discovery (South Africa)
  9. Horizon Blue Cross and Blue Shield
  10. McKinsey
  11. Weight Watchers
  12. CVS Caremark
  13. Pfizer Inc.

向作者/读者索取更多资源

Synchronizing medication refills-renewing all medications at the same time from the same pharmacy-is an increasingly popular strategy to improve adherence to medication regimens, but there has been little research regarding its effectiveness. In light of increasing policy interest, we evaluated the impact of a pilot refill synchronization program implemented by a large national insurer. A random sample of Medicare Advantage patients receiving mail-order refills for common maintenance medications (antihypertensive, lipid-lowering, or antidiabetic agents) were invited to join the program and followed for twelve months. On average, the absolute increase in the proportion of patients deemed adherent during follow-up was 3-10 percentage points for the intervention group, compared to 1-5 percentage points for the control group. Patients with poorer baseline adherence showed larger increases in the absolute proportion deemed adherent in intervention (23-26 percentage points) compared to a control group (13-15 percentage points). Synchronizing refills might be a promising intervention to improve adherence to maintenance medications, especially among Medicare patients with low baseline adherence.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据